{
  "trial_id": "NCT00126594",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, absolute neutrophil count, platelet count, hemoglobin level, total bilirubin, albumin level, serum creatinine, AST (SGOT) level, ALT (SGPT) level, presence of liver metastases, plasma beta human chorionic gonadotropin (\u03b2HCG) level, history of major psychiatric illness, ability to comply with study procedures, ability to swallow pills, history of prior malignancy, history of systemic anticancer therapy for renal cell carcinoma, history of radiotherapy for renal cell carcinoma, history of primary brain tumor or brain metastases, history of acute infections, history of cardiovascular disease, history of hypertension, history of other diseases or metabolic dysfunctions, pregnancy status, HIV status, history of coagulopathy or thrombosis, history of severe depression, concomitant treatment with specific drugs.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "ECOG (Performance Status)",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Nephrectomy",
        "Memorial Sloan-Kettering Cancer Center (MSKCC) Prognostic Risk",
        "Number of Metastatic Sites",
        "Sites of Metastatic Disease"
      ],
      "remaining_candidate_features": [
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin level",
        "total bilirubin",
        "albumin level",
        "serum creatinine",
        "AST (SGOT) level",
        "ALT (SGPT) level",
        "presence of liver metastases",
        "plasma beta human chorionic gonadotropin (\u03b2HCG) level",
        "history of major psychiatric illness",
        "ability to comply with study procedures",
        "ability to swallow pills",
        "history of prior malignancy",
        "history of systemic anticancer therapy for renal cell carcinoma",
        "history of radiotherapy for renal cell carcinoma",
        "history of primary brain tumor or brain metastases",
        "history of acute infections",
        "history of cardiovascular disease",
        "history of hypertension",
        "history of other diseases or metabolic dysfunctions",
        "pregnancy status",
        "HIV status",
        "history of coagulopathy or thrombosis",
        "history of severe depression",
        "concomitant treatment with specific drugs"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Gender, Race/Ethnicity, ECOG performance status, Absolute neutrophil count, Platelet count, Hemoglobin level, Total bilirubin, Albumin level, Serum creatinine, AST(SGOT) level, ALT(SGPT) level, Presence of liver metastases, Prior malignancy history, Cardiovascular disease history, Hypertension status, Coagulopathy history, Depression history,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "ECOG (Performance Status)",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Nephrectomy",
        "Memorial Sloan-Kettering Cancer Center (MSKCC) Prognostic Risk",
        "Number of Metastatic Sites",
        "Sites of Metastatic Disease"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Absolute neutrophil count",
        "Platelet count",
        "Hemoglobin level",
        "Total bilirubin",
        "Albumin level",
        "Serum creatinine",
        "AST(SGOT) level",
        "ALT(SGPT) level",
        "Presence of liver metastases",
        "Prior malignancy history",
        "Cardiovascular disease history",
        "Hypertension status",
        "Coagulopathy history",
        "Depression history"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histology, Number of Metastatic Sites, Prior Nephrectomy, Prior Systemic Therapy, Baseline Hemoglobin, Baseline Creatinine, Baseline Albumin, Baseline AST, Baseline ALT, Baseline Platelet Count, Baseline Neutrophil Count.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "ECOG (Performance Status)",
          "ECOG Performance Status"
        ],
        [
          "Number of Metastatic Sites",
          "Number of Metastatic Sites"
        ],
        [
          "Nephrectomy",
          "Prior Nephrectomy"
        ]
      ],
      "remaining_reference_features": [
        "Memorial Sloan-Kettering Cancer Center (MSKCC) Prognostic Risk",
        "Sites of Metastatic Disease"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Histology",
        "Prior Systemic Therapy",
        "Baseline Hemoglobin",
        "Baseline Creatinine",
        "Baseline Albumin",
        "Baseline AST",
        "Baseline ALT",
        "Baseline Platelet Count",
        "Baseline Neutrophil Count"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, histological subtype of renal cell carcinoma, number and location of metastatic sites, prior nephrectomy, prior systemic therapy, absolute neutrophil count, platelets, hemoglobin, total bilirubin, albumin, serum creatinine, AST, ALT, beta human chorionic gonadotropin (\u03b2HCG) level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "ECOG (Performance Status)",
          "ECOG performance status"
        ],
        [
          "Nephrectomy",
          "prior nephrectomy"
        ],
        [
          "Number of Metastatic Sites",
          "number and location of metastatic sites"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Memorial Sloan-Kettering Cancer Center (MSKCC) Prognostic Risk",
        "Sites of Metastatic Disease"
      ],
      "remaining_candidate_features": [
        "race",
        "histological subtype of renal cell carcinoma",
        "prior systemic therapy",
        "absolute neutrophil count",
        "platelets",
        "hemoglobin",
        "total bilirubin",
        "albumin",
        "serum creatinine",
        "AST",
        "ALT",
        "beta human chorionic gonadotropin (\u03b2HCG) level"
      ]
    }
  }
}